Balchem (BCPC) Aktie Kurs
Balchem Kurs
De seneste 19 år voksede Balchems omsætning med 13,0 % årligt og nåede 1,04 Mrd. USD. Indtjening pr. aktie er vokset med 13,2 % om året de seneste 19 år. For Balchem er nettoavance på 14,9 % op i forhold til 12,0 % for et par år siden. Ved dagens kurs bliver direkteafkastet cirka 0,55 %. Udlodningsandelen er omkring 20 % af indtjeningen. Udbyttet er vokset med 15,7 % om året de seneste 19 år. Konsensus 12-måneders kursmål for Balchem er 215,00 USD, cirka over kursen med 24,2 %. Af 10 analytikere anbefaler 8 køb — den samlede vurdering er Køb.
Balchem aktiekurs
Hent disse data via Eulerpool API
100.000 requests/md. gratis · intet kreditkort
Balchem aktie og aktieanalyse
Hyppigt stillede spørgsmål om Balchem-aktien
Balchem Corp is a leading company with a unique business model. The company specializes in the development, manufacturing, and marketing of specialty performance ingredients and products, catering to various industries. Balchem Corp focuses on providing innovative solutions that enhance the health and well-being of people, animals, and plants. With a diverse portfolio, the company offers nutritional, flavor, and fragrance ingredients, as well as animal health products and specialty film solutions. Balchem Corp consistently aims to deliver high-quality products and services that meet the evolving needs of its customers, reinforcing its position as a trusted industry leader.
Balchem Corp is primarily active in the industries of nutrition and health, animal nutrition, specialty products, and industrial products.
The main competitors of Balchem Corp in the market include companies such as Archer Daniels Midland Company, Innophos Holdings Inc., and Corbion N.V.
Balchem Corp is a leading company in the specialty chemicals industry. Founded in 1967, Balchem Corp has established a strong reputation for delivering innovative solutions across various sectors including human and animal nutrition, food and beverage, and pharmaceuticals. The company's rich history spans over five decades, marked by continuous growth and strategic acquisitions. Balchem Corp remains committed to providing high-quality products and services, leveraging its expertise in encapsulation, chelation, and controlled release technologies. With a customer-centric approach and a focus on sustainable solutions, Balchem Corp continues to drive forward in its mission to enhance health and well-being through its diverse portfolio of products and cutting-edge research.
Balchem Corp has achieved several significant milestones in its history. One of the key milestones is its acquisition of certain assets of Animal Nutrition & Health (ANH) business from a leading global food company, AkzoNobel, in 2012. This acquisition allowed Balchem to expand its portfolio and become a leading provider of encapsulated nutraceuticals for both human and animal health markets. Additionally, the company has consistently demonstrated strong financial performance over the years, with increasing revenues and earnings. Furthermore, Balchem has established itself as a trusted name in the industry, known for its high-quality products and innovative solutions.
Balchem Corp is primarily present in the United States.
Balchem Corp represents a commitment to innovation, sustainability, and to making a positive impact in the industries it serves. The company focuses on delivering high-quality, science-based solutions that provide unique value to its customers. Balchem Corp places a strong emphasis on corporate responsibility, striving to operate in a socially and environmentally responsible manner. With a dedicated team and a customer-centric approach, the company aims to consistently provide exceptional products and services that meet the evolving needs of its clients.
Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 215,00 USD for Balchem-aktien (median: 215,00 USD), svarende til +24,2 % i forhold til seneste kurs. Konsensus bygger på 10 analytikervurderinger.
10 analytikere vurderer i øjeblikket Balchem-aktien: 8 anbefaler køb, 2 hold og 0 salg. For 2026 forventer analytikere, at Balchem genererer omsætning på 1,13 Mrd. USD og indtjening pr. aktie på 5,93 USD.
Omregnet til den aktuelle valutakurs handles Balchem-aktien til 156,86 EUR (173,14 USD).
Balchem-aktien (BCPC) er noteret på 5 børser, herunder: NASDAQ (BCPC), SIX (Zürich) (BL9B.SW), Frankfurt (BL9B.F), München (BL9B.MU), Düsseldorf (BL9B.DU).
Balchem Corp is a leading company in the fields of animal nutrition, human nutrition, and industrial chemicals. The innovative company offers a wide range of products and solutions tailored to the needs of its customers. Balchem's animal nutrition division provides solutions for animal feed enhancement, health, and well-being of livestock, pets, and aquaculture. Balchem's products help animal owners improve the health of their animals and increase growth and productivity. Balchem uses innovative technologies to offer its customers powerful and effective feed enhancement solutions that provide significant benefits for animal health and performance. Balchem's human nutrition division offers solutions tailored to the health and needs of the modern consumer. Balchem's products include functional ingredients, vitamins, minerals, and amino acids used in food, beverages, supplements, and pharmaceutical products. Balchem aims to improve human health and well-being by offering innovative products that help consumers maximize their health and happiness. Balchem's industrial chemicals division offers a variety of solutions for applications in agriculture, industry, and other industries. Balchem produces and distributes chemicals that can be used for many different purposes, including pesticides, defoliants, flame retardants, and many more. Balchem leverages its experience and expertise in the chemical industry to offer innovative solutions to its customers, helping them achieve their business goals. An example of a Balchem product is Choline Chloride, which is known as an essential nutrient for animals. It supports the growth and maintenance of cells and tissues, especially the nervous system. It is necessary for the synthesis of lecithin, which is an important component of any cell membrane. Overall, Balchem's business model is based on providing innovative, customer-oriented solutions tailored to the needs of its customers. The company has a strong focus on research and development of new products and technologies, which allows it to continuously enter new markets and remain competitive. By continuously evolving high-quality products and services, Balchem creates value for its customers and supports them in achieving their goals.
forventet-omsætningen for Balchem er 1,13 Mrd. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.
forventet-overskuddet for Balchem er 191,53 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.
Pris-til-indtjening-forholdet (P/E) for Balchem er i øjeblikket 29,22. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Balchem-aktien.
Pris-til-salgs-forholdet (P/S) for Balchem er i øjeblikket 4,94. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Balchem-aktien.
AlleAktien-kvalitetsscore for Balchem er 6/10.
ISIN for Balchem er US0576652004. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.
WKN for Balchem er 905650. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.
Tickeren for Balchem er BCPC. Tickersymbolet bruges til at handle Balchem-aktier på børsen.
Balchem aktie
Balchem Peer Group
Balchem Ticker
Balchem FIGI
Alle fundamentale data om Balchem i deep dive
Vores aktieanalyse af Balchem-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Balchem. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: